PINKSimplify Health Care ETF
Seeks long-term capital appreciation.
By Simplify Asset Management · Launched 2021
Annual Cost
0.51%
#2,701 of 5,562 · average
Fund Size
$267M
#2,067 of 5,562 · mid-size
Return (1Y)Goal
+26.0%
Track Record
4 years
#2,517 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,647+26.5%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 54.1% of fundmoderately concentrated
UnitedHealth Group Inc
9.4%
Eli Lilly & Co
8.7%
Regeneron Pharmaceuticals Inc
7.4%
Amgen Inc
4.9%
Align Technology Inc
4.8%
PureCycle Technologies Inc
4.8%
Apellis Pharmaceuticals Inc
3.9%
Jazz Pharmaceuticals PLC
3.5%
DREYFUS TRSY OBLIG CASH M
3.3%
United Therapeutics Corp
3.3%
Asset allocation
Stocks
98.8%
Cash
1.2%
By sector
Healthcare
89.5%
Industrials
10.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
18.5%Moderate
Year-on-year price swings
Max drawdown
-18.8%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.61Decent risk-adjusted returns
Sortino (3Y)
0.88Moderate downside risk
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks long-term capital appreciation.
- Strategy
- Invests primarily in U.S. health care companies, defined by the Global Industry Classification Standard. The Fund employs a growth strategy, focusing on companies with earnings expected to grow faster than inflation, while also considering value opportunities when valuations are high. It targets 50 to 100 health care companies, including micro-capitalization firms, and may invest in affiliated money market ETFs for liquidity management.
- Inception date
- October 7, 2021
- Fund family
- Simplify Asset Management
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed PINK. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19